Impact of host cell line choice on glycan profile

被引:161
作者
Goh, Justin Bryan [1 ]
Ng, Say Kong [1 ]
机构
[1] ASTAR, Bioproc Technol Inst, Singapore, Singapore
基金
新加坡国家研究基金会;
关键词
Glycosylation; expression system; immunoglobulin G (IgG); coagulation factor VII (FVII); erythropoietin (EPO); alpha-1 antitrypsin (A1AT); N-LINKED OLIGOSACCHARIDES; HAMSTER OVARY CELLS; GLCNAC-GLYCOPEPTIDE BETA-4-N-ACETYLGLUCOSAMINYLTRANSFERASE-III; RECOMBINANT THERAPEUTIC PROTEINS; ENGINEERED NICOTIANA-BENTHAMIANA; NONHUMAN SIALIC-ACID; FACTOR-VII RFVIIA; GLYCOLYLNEURAMINIC ACID; HUMAN IGG1; STRUCTURAL-CHARACTERIZATION;
D O I
10.1080/07388551.2017.1416577
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Protein glycosylation is post-translational modification (PTM) which is important for pharmacokinetics and immunogenicity of recombinant glycoprotein therapeutics. As a result of variations in monosaccharide composition, glycosidic linkages and glycan branching, glycosylation introduces considerable complexity and heterogeneity to therapeutics. The host cell line used to produce the glycoprotein has a strong influence on the glycosylation because different host systems may express varying repertoire of glycosylation enzymes and transporters that contributes to specificity and heterogeneity in glycosylation profiles. In this review, we discuss the types of host cell lines currently used for recombinant therapeutic production, their glycosylation potential and the resultant impact on glycoprotein properties. In addition, we compare the reported glycosylation profiles of four recombinant glycoproteins: immunoglobulin G (IgG), coagulation factor VII (FVII), erythropoietin (EPO) and alpha-1 antitrypsin (A1AT) produced in different mammalian cells to establish the influence of mammalian host cell lines on glycosylation.
引用
收藏
页码:851 / 867
页数:17
相关论文
共 161 条
[1]  
ADAMSON JW, 1990, ANNU REV MED, V41, P349
[2]   Increased serum clearance of oligomannose species present on a human IgG1 molecule [J].
Alessandri, Leslie ;
Ouellette, David ;
Acquah, Aima ;
Rieser, Mathew ;
LeBlond, David ;
Saltarelli, Mary ;
Radziejewski, Czeslaw ;
Fujimori, Taro ;
Correia, Ivan .
MABS, 2012, 4 (04) :509-520
[3]   Manipulating the glycosylation pathway in bacterial and lower eukaryotes for production of therapeutic proteins [J].
Anyaogu, Diana Chinyere ;
Mortensen, Uffe Hasbro .
CURRENT OPINION IN BIOTECHNOLOGY, 2015, 36 :122-128
[4]   On the frequency of protein glycosylation, as deduced from analysis of the SWISS-PROT database [J].
Apweiler, R ;
Hermjakob, H ;
Sharon, N .
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 1999, 1473 (01) :4-8
[5]   Interaction of mannan binding lectin with α2 macroglobulin via exposed oligomannose glycans -: A conserved feature of the thiol ester protein family? [J].
Arnold, JN ;
Wallis, R ;
Willis, AC ;
Harvey, DJ ;
Royle, L ;
Dwek, RA ;
Rudd, PM ;
Sim, RB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (11) :6955-6963
[6]   High-Throughput IgG Fc N-Glycosylation Profiling by Mass Spectrometry of Glycopeptides [J].
Bakovic, Maja Pucic ;
Selman, Maurice H. J. ;
Hoffmann, Marcus ;
Rudan, Igor ;
Campbell, Harry ;
Deelder, Andre M. ;
Lauc, Gordan ;
Wuhrer, Manfred .
JOURNAL OF PROTEOME RESEARCH, 2013, 12 (02) :821-831
[7]   Mechanism of uptake and incorporation of the non-human sialic acid N-glycolylneuraminic acid into human cells [J].
Bardor, M ;
Nguyen, DH ;
Diaz, S ;
Varki, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (06) :4228-4237
[8]   Advances in animal cell recombinant protein production: GS-NS0 expression system [J].
Barnes L.M. ;
Bentley C.M. ;
Dickson A.J. .
Barnes, L.M., 2000, Springer Netherlands (32) :109-123
[9]  
BERKNER KL, 1993, METHOD ENZYMOL, V222, P450
[10]   Virus Susceptibility of Chinese Hamster Ovary (CHO) Cells and Detection of Viral Contaminations by Adventitious Agent Testing [J].
Berting, Andreas ;
Farcet, Maria R. ;
Kreil, Thomas R. .
BIOTECHNOLOGY AND BIOENGINEERING, 2010, 106 (04) :598-607